2019 Preferred Provider Organization Medicare Advantage ...

The Interface Formulary for Adults has a preference to avoid combination products unless there is an overwhelming advantage. FWG did not judge there to be such an advantage in this instance February 2013 Fampridine DECLINED – UHB declined the addition of the drug onto the formulary due to the limited trial data available at present and the ... ................
................